View Source BMJ (Clinical research ed.) Use of melanotan I and II in the general population 2009 DOI: 10.1136/bmj.b566 PMID: 19224885 Evans-Brown M, Dawson RT, Chandler M, et al
Lush Rx in Bellaire, TX now offers an oral GLP-1 option
Key Takeaways CagriSema and Retatrutide are both investigational: Neither is FDA-approved for obesity or diabetes treatment as of May 2026
By addressing the root causes of weight gain, it delivers sustainable, long-term results without harsh digestive side effects
A bestseller at Beyond Peptides third-party verified quality with fast European delivery and bulk vial discounts
J Neurochem 104:113123 Czeredys M, Mysiorek C, Kulikova N, Samluk L, Berezowski V, Cecchelli R, Nalecz KA (2008) A polarized localization of amino acid/carnitine transporter B(0,+) (ATB(0,+)) in the bloodbrain barrier